search
Back to results

Surgical Consent Process for Trans-obturator Tape Slings.

Primary Purpose

Urinary Incontinence, Stress

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Informational Handout
Sponsored by
Boston Urogynecology Associates
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Urinary Incontinence, Stress focused on measuring Urinary Incontinence, Stress [C13.351.968.934.814.500]

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult women ≥age 18
  • Consented for TOT mid-urethral sling
  • Able to read and understand English

Exclusion Criteria:

  • History of surgical treatment for stress urinary incontinence using mid-urethral slings.
  • Patients undergoing concomitant Trans-Obturator Post-Anal Sling (TOPAS) surgery.

Sites / Locations

  • Mount Auburn HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Other

Arm Label

Control group

Intervention group

Arm Description

Participants will receive only the standard verbal TOT surgical consent counseling.

Participants will receive the standard verbal TOT surgical consent counseling plus a handout describing their surgical intervention

Outcomes

Primary Outcome Measures

A knowledge questionnaire at the pre-operative holding area to measure the patients' knowledge regarding their Trans Obturator Tape surgery. The percentage of correct answers will be reported and analyzed.

Secondary Outcome Measures

Full Information

First Posted
April 14, 2016
Last Updated
January 17, 2018
Sponsor
Boston Urogynecology Associates
search

1. Study Identification

Unique Protocol Identification Number
NCT02750878
Brief Title
Surgical Consent Process for Trans-obturator Tape Slings.
Official Title
A Randomized Controlled Trial of the Consent Process for Patients Undergoing Trans-obturator Tape Slings.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Unknown status
Study Start Date
November 2015 (Actual)
Primary Completion Date
July 2019 (Anticipated)
Study Completion Date
July 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Urogynecology Associates

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine if addition of a handout to the standard consent process for the trans-obturator tape (TOT) mid-urethral sling procedure will improve patients' understanding, recall and satisfaction with their procedure. The information provided in the handout will include the procedure details, the accompanying risks and benefits, as well as the expectations and alternatives to the TOT procedure. The aim of the investigators is to improve and standardize the current process for surgical consent for patients undergoing a mid-urethral sling procedure, specifically the TOT. The investigators hypothesize that addition of a handout will improve patient's preoperative comprehension by an absolute value of 10% compared to the standard consent process. The investigators further hypothesize that the handout will improve patient satisfaction and recall of the surgical procedure details post operatively.
Detailed Description
This is a randomized controlled trial investigating whether adding an informational handout to the standard surgical consent will improve patient understanding, recall and satisfaction with their surgery. The primary outcome will be the patient's knowledge of her surgical details immediately before surgery. The secondary outcomes will be the patient's satisfaction, regret scale and the patient's postoperative knowledge of her surgery details. A member of the research team will recruit eligible patients at their preoperative clinic visit during the signing of consent for their TOT surgery. Verbal counseling for the TOT surgical consent is the current standard of practice in the investigator's office. After the patient is counseled in the usual fashion and signs the consent for her planned TOT surgery, the patient will be offered participation in the study. Eligible patients will be consented verbally by the investigators. After enrollment, patients will be randomized using a computer-generated block randomization scheme to allocate participants in a 1:1 ratio; randomization will be stratified by provider. Participants will be randomized to one of two study arms: Control Group: Participants will receive only the standard verbal TOT surgical consent counseling described above. Intervention Group: Participants will receive the standard verbal TOT surgical consent counseling plus a handout describing their surgical intervention. All participants will be asked to complete a baseline questionnaire at the enrollment visit. Participants randomized to the control group will be finished with this initial study visit after completing the baseline questionnaire. Participants randomized to the intervention arm will be given a handout describing the TOT procedure, risks and benefits, post-operative recovery and alternative treatment options, as discussed in the verbal surgical consent. The patient will be asked to read the handout and will then be given the handout to take home. The provider will answer any questions the patient has after reviewing the handout. The next study encounter will occur in the preoperative area immediately prior to surgery. At this time all participants will be asked to complete a second questionnaire with questions similar to those in the baseline questionnaire. The final study encounter will occur at the post-operative visit that occurs approximately six weeks after surgery. At this visit all participants will be asked to complete a final questionnaire. This questionnaire will be the same as the one administered immediately before surgery. All participants will also be asked to complete an additional questionnaire asking about satisfaction, regret and surgical experience.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence, Stress
Keywords
Urinary Incontinence, Stress [C13.351.968.934.814.500]

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
Participants will receive only the standard verbal TOT surgical consent counseling.
Arm Title
Intervention group
Arm Type
Other
Arm Description
Participants will receive the standard verbal TOT surgical consent counseling plus a handout describing their surgical intervention
Intervention Type
Other
Intervention Name(s)
Informational Handout
Primary Outcome Measure Information:
Title
A knowledge questionnaire at the pre-operative holding area to measure the patients' knowledge regarding their Trans Obturator Tape surgery. The percentage of correct answers will be reported and analyzed.
Time Frame
On the day of Trans Obturator Tape surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult women ≥age 18 Consented for TOT mid-urethral sling Able to read and understand English Exclusion Criteria: History of surgical treatment for stress urinary incontinence using mid-urethral slings. Patients undergoing concomitant Trans-Obturator Post-Anal Sling (TOPAS) surgery.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eman Elkadry, MD
Phone
617-354-5452
Email
eelkadry@mah.harvard.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Hussein Warda, MD
Phone
617-354-5452
Email
hwarda@mah.harvard.edu
Facility Information:
Facility Name
Mount Auburn Hospital
City
Cambridge
State/Province
Massachusetts
ZIP/Postal Code
02138
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kathleen Rogers
Phone
617-354-5452
Email
krogers2@mah.harvard.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Surgical Consent Process for Trans-obturator Tape Slings.

We'll reach out to this number within 24 hrs